Is 4551.T stock a buy after the oversold bounce?

4551.T stock shows a short-term bounce opportunity. For traders, a tight entry and stop work. For longer-term investors, mixed fundamentals and a PE of 33.00 argue for Hold until clearer earnings or regulatory catalysts emerge.

What price target does Meyka AI show for 4551.T stock?

Meyka AI's forecast model projects **1-year: 5,526.11 JPY** and **3-year: 6,581.12 JPY**. That implies about **-12.97%** at 1 year and **+3.64%** at 3 years versus the current **6,350.00 JPY**.

What are the main risks for 4551.T stock?

Main risks for 4551.T stock include regulatory setbacks, pricing pressure in generics, and slow collections given days sales outstanding near **159.93**. A negative clinical update could quickly erase short-term gains.

How should I size a trade on 4551.T stock for the oversold bounce?

Size trades small and use a stop-loss around **6,100.00 JPY** with a first target near **6,700.00 JPY**. Given mixed fundamentals, limit position to a small percentage of the portfolio and scale out on volume-confirmed gains.

JP Stocks

JPX close: Torii Pharmaceutical (4551.T) at JPY 6,350 on 29 Jan 2026 : watch for an oversold bounce

ByHuzaifa Zahoor January 29, 2026

4551.T stock closed on the JPX at 6,350.00 JPY on 29 Jan 2026, showing an early oversold bounce setup after a pullback toward the year low. Volume was 48,100 shares, slightly below the 49,218 average. The short-term technical picture points to a low-risk mean-reversion trade while fundamentals keep a mixed longer-term view.